Skip to main content

Table 1 Baseline characteristics at the time of the index AMI and corresponding values at 2 years of follow-up

From: Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations

  At baseline n = 200 At 2 years of follow-up n = 200 P-values
Age 63.3 ± 9.7 65.5 ± 9,8  
Smoker 45 (22.5) 25 (12.5) < 0.001
Overweight* 129 (65.5) 144 (72) < 0.001
Systolic BP (mmHg) 146.8 ± 23.4 137.5 ± 18.0 < 0.001
Diastolic BP (mmHg) 91.3 ± 15.0 79.6 ± 10.3 < 0.001
Heart rate (beats/min) 75.6 ± 18.8 62.1 ± 10.6 < 0.001
Hypertension 102 (51.0) 123 (63.4) (n = 194)# 0.157
Hyperlipidemia 53 (26.5) 115 (63.5) (n = 181)# 0.209
Diabetes type1/type2 26 (13.0) 43 (21.8) (n = 197)# 0.259
Heart failure 6 (3.0) 14 (7) < 0.001
Atrial fibrillation 8 (4.0) 29 (14.8) (n = 196)# 0.439
Stroke or TIA 12 (6.0) 14 (7.2) (n = 194)# 0.319
Renal failure 4 (2.0) 9 (4.5) < 0.001
Aspirin 199 (99.5) 183 (91.5) (n = 199)# 0.774
Betablockers 187 (93.5) 166 (84.3) (n = 197)# 0.452
Statins 193 (96.5) 177 (89.4) (n = 198)# 0.628
ACE-inhibitors or ARB 177 (88.5) 153 (76.5) 0.463
  1. *BMI ≥ 25 kg/m2. BP Blood pressure, IHD Ischemic heart disease, TIA Transient ischemic attack, ACE Angiotensin converting enzyme, ARB Angiotensin receptor blockers. Data are expressed as mean ± SD or n (%)
  2. #Actual number of patients at 2 years of follow-up